Related Experiment Video

Updated: May 28, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

The effects of CD59 gene as a target gene on breast cancer cells

Bing Li1, Xianming Chu, Meihua Gao

  • 1Department of Biology, Medical College of Qingdao University, 38 Dengzhou Road, Qingdao, PR China. libing_516@yahoo.com.cn

Cellular Immunology
|October 18, 2011
PubMed

Insights

Gene silencing of CD59 in breast cancer cells triggers apoptosis and suppresses tumor growth. This study highlights CD59 as a potential therapeutic target for breast cancer gene therapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Therapy

Background:

  • The CD59 gene plays a role in cell protection and proliferation.
  • Understanding CD59's function is crucial for developing novel breast cancer therapies.

Purpose of the Study:

  • To investigate the effect of CD59 gene suppression on MCF-7 breast cancer cells.
  • To evaluate CD59 as a potential target for breast cancer gene therapy.

Main Methods:

  • Construction and transfection of a retroviral vector (pSUPER-siCD59) targeting the CD59 gene in MCF-7 cells.
  • RNA interference (RNAi) was used to suppress CD59 expression at both mRNA and protein levels.
  • Analysis of apoptosis-related proteins (Fas, caspase-3, Bcl-2) and cell proliferation.

Main Results:

  • Retroviral vector-mediated RNAi effectively suppressed CD59 expression in MCF-7 cells.
  • CD59 knockdown abrogated complement-mediated cytolysis protection and induced apoptosis via upregulation of Fas and caspase-3.
  • Overexpression of CD59 promoted MCF-7 cell proliferation and inhibited anti-apoptotic Bcl-2 expression.

Conclusions:

  • CD59 plays a significant role in breast cancer cell proliferation and survival.
  • Suppression of CD59 induces apoptosis and inhibits tumor growth.
  • CD59 represents a promising molecular target for breast cancer gene therapy.

More Related Videos

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...